T Cell Surface Glycoprotein CD Market
Global T Cell Surface Glycoprotein CD Market Size, Share &Trends Analysis Report by Type (CD3, CD4, CD5 And Other), And by Application (HIV, AIDS, GVHD, SARS, Cancer and Other) Forecast (2022-2028)
The global T cell surface glycoprotein CD market is anticipated to grow at a significant CAGR during the forecast period (2022-2028).T cell surface glycoprotein CD is a type of protein that is found in the human body. It plays an important role in immune system responses which are made by the body. It is mainly present on the surface of T lymphocyte cells. When the T cell receptor is activated by antigen cells, CD3 chains mediate TCR-mediated signals that are transmitted across the cell membrane. These CD3 chains in their basic cytoplasmic receptor contain immunoreceptor activation motifs. Apart from signal transduction, CD3 also plays an important role in the differentiation of thymocytes.
Impact of COVID-19 Pandemic on Global T cell surface glycoprotein CD Market
COVID-19 pandemic has a negative effect on the global T cell surface glycoprotein CD market. During the COVID 19 pandemic; people were not able to go to hospital facilities as there was nationwide lockdown in almost all parts of the world. Treatment or injection of this drug needs to be given in a healthcare facility under expert supervision which was not possible during the pandemic which indirectly hamper the market.
Segmental Outlook
The global T cell surface glycoprotein CD market is segmented based on type, and application. Based on type, the market is segmented into CD3, CD4, CD5, And Other. Based on application the market is sub-segmented HIV, AIDS, GVHD, SARS, CANCER, and others. Among these, the HIV segment is anticipated to grow during the forecast period due to the increasing number of people suffering from HIV. According to the World Health Organization (WHO), an estimated 37.7 million people were living with HIV at the end of 2020.
Global T Cell Surface Glycoprotein CD Market Share by CD4, 2021 (%)
CD4 Segment is Anticipated to Hold a Prominent Market Share in the Global T Cell Surface Glycoprotein CD Market
CD4 segment is anticipated to hold a prominent market share in the global T cell surface glycoprotein CD market during the forecast period. There are tests that measure CD4 cells in the blood in the human body. These cells are also known as T cells. They are a kind of white blood cells that fight infection in the human body. CD4 cells are tested in the human body to check their count. This is done in people who are infected with HIV to check their immune systems. For people who have HIV, CD4 cells are destroyed in their bodies. This poses a negative impact on the body.
Regional Outlooks
The global T cell surface glycoprotein CD market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). Asia Pacific region is considered to be the fastest-growing market due to the growing improvement in healthcare infrastructure and the development of hospitals equipped with advanced medical facilities across the region.
Global T Cell Surface Glycoprotein CD Market Growth, by Region 2022-2028
North America is Estimated to Hold the Prominent Share in the Global T Cell Surface Glycoprotein CD Market
North America is estimated to hold a prominent share in the global T cell surface glycoprotein CD market. The major factor that drives the global T cell surface glycoprotein CD market in this region is attributed to the increasing number of people suffering from cancer and the increasing number of mortalities in most parts of the US due to cancer. For instance, in Feb 2021, the American cancer society has estimated that a total number of 970,250 cases of cancer will be diagnosed in 2022. Prostate cancer, lung cancer, colon cancer, and cancer in the urinary bladder will see the highest surge in men.
Market Players Outlook
The major companies serving the global T cell surface glycoprotein CD market include Bristol-Myers Squib Corp., Johnson and Johnson Services Inc., Biotest AG, CEL-SCI Corp., Fountain Biopharma Inc., and others. The market players are adopting different market strategies such as mergers and acquisitions, new product launches, business expansion, partnership collaboration, and others. For instance, in February 2022, scientists who are from the University hospital Seidman cancer center and case Western Reserve University have said that CAR T cell therapy has shown success in preclinical studies. They have said that the new therapy on cancer cells can triple the antigens.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global T cell surface glycoprotein CD market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on The Global T Cell Surface Glycoprotein CD Market
- Recovery Scenario of Global T Cell Surface Glycoprotein CD Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Bristol-Myers Squibb Corp.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Johnson and Johnson Services, Inc.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Biotest AG
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. CEL-SCI Corp.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Fountain Biopharma, Inc.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global T Cell Surface Glycoprotein CD Market by Type
4.1.1. CD3
4.1.2. CD4
4.1.3. CD5
4.1.4. Others
4.2. Global T Cell Surface Glycoprotein CD Market by Application
4.2.1. HIV
4.2.2. AIDS
4.2.3. GVHD
4.2.4. SARS
4.2.5. Cancer
4.2.6. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Amgen Inc
6.2. bluebird bio, Inc.
6.3. CELGENE CORP
6.4. Fate Therapeutics
6.5. Gilead Sciences, Inc
6.6. ImmuPharma PLC
6.7. Merck KGaA
6.8. Novartis AG
6.9. Pfizer Inc.
6.10. Sanofi
6.11. Sorrento Therapeutics, Inc.
6.12. TaiMed Biologics, Inc.
6.13. TCR² Therapeutics.
6.14. United Biomedical Inc.
1. GLOBALT CELL SURFACE GLYCOPROTEIN CD MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL T CELL SURFACE GLYCOPROTEIN CD3 MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL T CELL SURFACE GLYCOPROTEIN CD4 MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL T CELL SURFACE GLYCOPROTEIN CD5 MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL T CELL SURFACE GLYCOPROTEIN OTHER CDS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL T CELL SURFACE GLYCOPROTEIN CD MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
7. GLOBAL T CELL SURFACE GLYCOPROTEIN CD FOR HIV MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL T CELL SURFACE GLYCOPROTEIN CD FOR AIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL T CELL SURFACE GLYCOPROTEIN CD FOR GVHD MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL T CELL SURFACE GLYCOPROTEIN CD FOR SARS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL T CELL SURFACE GLYCOPROTEIN CD FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL T CELL SURFACE GLYCOPROTEIN CD FOR OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBALT CELL SURFACE GLYCOPROTEIN CD MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
14. NORTH AMERICAN T CELL SURFACE GLYCOPROTEIN CD MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15. NORTH AMERICAN T CELL SURFACE GLYCOPROTEIN CD MARKET RESEARCH AND ANALYSIS BYTYPE, 2021-2028 ($ MILLION)
16. NORTH AMERICAN T CELL SURFACE GLYCOPROTEIN CD MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
17. EUROPEAN T CELL SURFACE GLYCOPROTEIN CD MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
18. EUROPEAN T CELL SURFACE GLYCOPROTEIN CD MARKET RESEARCH AND ANALYSIS BYTYPE, 2021-2028 ($ MILLION)
19. EUROPEAN T CELL SURFACE GLYCOPROTEIN CD MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
20. ASIA-PACIFIC T CELL SURFACE GLYCOPROTEIN CD MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
21. ASIA-PACIFIC T CELL SURFACE GLYCOPROTEIN CD MARKET RESEARCH AND ANALYSIS BYTYPE, 2021-2028 ($ MILLION)
22. ASIA-PACIFIC T CELL SURFACE GLYCOPROTEIN CD MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
23. REST OF THE WORLD T CELL SURFACE GLYCOPROTEIN CD MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
24. REST OF THE WORLD T CELL SURFACE GLYCOPROTEIN CD MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
25. REST OF THE WORLD T CELL SURFACE GLYCOPROTEIN CD MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL T CELL SURFACE GLYCOPROTEIN CD MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL T CELL SURFACE GLYCOPROTEIN CD MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL T CELL SURFACE GLYCOPROTEIN CD MARKET, 2021-2027 (%)
4. GLOBAL T CELL SURFACE GLYCOPROTEIN CD MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL T CELL SURFACE GLYCOPROTEIN CD3 MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL T CELL SURFACE GLYCOPROTEIN CD4 MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL T CELL SURFACE GLYCOPROTEIN CD5 MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL TCELL SURFACE GLYCOPROTEIN OTHER CD MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL T CELL SURFACE GLYCOPROTEIN CD MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
10. GLOBAL T CELL SURFACE GLYCOPROTEIN CD FOR HIV MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL T CELL SURFACE GLYCOPROTEIN CD FOR AIDS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL T CELL SURFACE GLYCOPROTEIN CD FOR GVHD MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL T CELL SURFACE GLYCOPROTEIN CD FOR SARS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL T CELL SURFACE GLYCOPROTEIN CD FR CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL T CELL SURFACE GLYCOPROTEIN CD FOR OTHER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL T CELL SURFACE GLYCOPROTEIN CD MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. US T CELL SURFACE GLYCOPROTEIN CD MARKET SIZE, 2021-2028 ($ MILLION)
18. CANADA T CELL SURFACE GLYCOPROTEIN CD MARKET SIZE, 2021-2028 ($ MILLION)
19. UK T CELL SURFACE GLYCOPROTEIN CD MARKET SIZE, 2021-2028 ($ MILLION)
20. FRANCE T CELL SURFACE GLYCOPROTEIN CD MARKET SIZE, 2021-2028 ($ MILLION)
21. GERMANY T CELL SURFACE GLYCOPROTEIN CD MARKET SIZE, 2021-2028 ($ MILLION)
22. ITALY T CELL SURFACE GLYCOPROTEIN CD MARKET SIZE, 2021-2028 ($ MILLION)
23. SPAIN T CELL SURFACE GLYCOPROTEIN CD MARKET SIZE, 2021-2028 ($ MILLION)
24. REST OF EUROPE T CELL SURFACE GLYCOPROTEIN CD MARKET SIZE, 2021-2028 ($ MILLION)
25. INDIA T CELL SURFACE GLYCOPROTEIN CD MARKET SIZE, 2021-2028 ($ MILLION)
26. CHINA T CELL SURFACE GLYCOPROTEIN CD MARKET SIZE, 2021-2028 ($ MILLION)
27. JAPAN T CELL SURFACE GLYCOPROTEIN CD MARKET SIZE, 2021-2028 ($ MILLION)
28. SOUTH KOREA T CELL SURFACE GLYCOPROTEIN CD MARKET SIZE, 2021-2028 ($ MILLION)
29. REST OF ASIA-PACIFIC T CELL SURFACE GLYCOPROTEIN CD MARKET SIZE, 2021-2028 ($ MILLION)
30. REST OF THE WORLD T CELL SURFACE GLYCOPROTEIN CD MARKET SIZE, 2021-2028 ($ MILLION)
